Results
31
Companies with a Future performance score of at least 3, ordered by Future performance score.
31 companies
Ascelia Pharma
Market Cap: SEK 294.1m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 3.06
7D
-3.6%
1Y
-71.1%
Elicera Therapeutics
Market Cap: SEK 214.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 4.42
7D
30.4%
1Y
370.2%
Corline Biomedical
Market Cap: SEK 266.9m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 10.90
7D
21.4%
1Y
3.3%
Camurus
Market Cap: SEK 34.6b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.
CAMX
SEK 590.00
7D
5.0%
1Y
18.4%
Bonesupport Holding
Market Cap: SEK 19.7b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 299.00
7D
-3.9%
1Y
32.3%
Devyser Diagnostics
Market Cap: SEK 1.6b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 95.00
7D
-5.0%
1Y
-3.8%
Xbrane Biopharma
Market Cap: SEK 299.2m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.20
7D
6.1%
1Y
-9.8%
BioArctic
Market Cap: SEK 17.2b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 194.80
7D
9.9%
1Y
-0.1%
Newbury Pharmaceuticals
Market Cap: SEK 74.7m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 3.08
7D
-9.1%
1Y
-9.7%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 157.8m
Operates as a pharmaceutical company.
KLAR
SEK 1.09
7D
0%
1Y
190.7%
SenzaGen
Market Cap: SEK 165.8m
Provides non-animal tests for assessing a substance’s allergenicity.
SENZA
SEK 5.62
7D
10.6%
1Y
-19.7%
Egetis Therapeutics
Market Cap: SEK 1.4b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 3.77
7D
8.0%
1Y
-40.9%
BioInvent International
Market Cap: SEK 2.0b
A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 30.90
7D
9.6%
1Y
18.8%
Active Biotech
Market Cap: SEK 104.8m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.085
7D
-5.3%
1Y
-84.8%
Hansa Biopharma
Market Cap: SEK 1.7b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 25.24
7D
12.2%
1Y
-12.8%
Moberg Pharma
Market Cap: SEK 359.5m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 7.70
7D
-2.5%
1Y
-77.4%
Xspray Pharma
Market Cap: SEK 1.2b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 33.15
7D
-9.2%
1Y
-18.1%
Modus Therapeutics Holding
Market Cap: SEK 45.6m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 1.27
7D
-0.8%
1Y
26.4%
AddLife
Market Cap: SEK 21.3b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 174.40
7D
13.8%
1Y
70.0%
Magle Chemoswed Holding
Market Cap: SEK 562.1m
Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.
MAGLE
SEK 27.40
7D
-4.9%
1Y
-9.3%
BICO Group
Market Cap: SEK 2.6b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 36.70
7D
1.8%
1Y
-20.7%
Swedencare
Market Cap: SEK 6.0b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 37.80
7D
5.1%
1Y
-33.2%
Biotage
Market Cap: SEK 11.3b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 140.80
7D
-0.1%
1Y
-16.2%
AlzeCure Pharma
Market Cap: SEK 210.1m
A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.38
7D
-1.7%
1Y
25.9%
FluoGuide
Market Cap: SEK 543.4m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 39.90
7D
3.6%
1Y
-26.1%
Lipigon Pharmaceuticals
Market Cap: SEK 17.8m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.12
7D
-0.4%
1Y
-64.7%
Vitrolife
Market Cap: SEK 20.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 150.40
7D
-1.4%
1Y
-9.6%
Cantargia
Market Cap: SEK 408.2m
A biotechnology company, develops antibody-based treatments for life threatening diseases.
CANTA
SEK 1.64
7D
4.9%
1Y
-50.8%
SynAct Pharma
Market Cap: SEK 947.8m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 19.34
7D
4.7%
1Y
182.7%
BioGaia
Market Cap: SEK 10.1b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 99.45
7D
-1.1%
1Y
-15.6%
Guard Therapeutics International
Market Cap: SEK 265.2m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 13.15
7D
1.9%
1Y
-55.0%